Pharmafile Logo

social media

- PMLiVE

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir

Raises concerns over patent exclusivity in the country

- PMLiVE

UPDATED: J&J expands US partnership for coronavirus treatments

Expands on exisiting alliance announced last week

Article: Like, Like, Like: Harnessing the power of social media insights

Given the colossal amount of personal and professional information that we share online, social media channels such as Facebook and Twitter are fast becoming treasure troves of big data. As...

Research Partnership

- PMLiVE

UK no longer measles-free as vaccination rates fall dramatically

PM Boris Johnson calls for urgent action

- PMLiVE

The social dilemma: is it time for pharma to join the party?

Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun

The Social Dilemma

In the June issue of PME, Dennis O’Brien, Lucid CEO, explores the relationship between social media and pharma.“There is a party going on next door, but our industry is too...

Lucid Group Communications Limited

Fake News is Bad for your Health

Ill informed patients make poor health decisions

Life Healthcare Communications

- PMLiVE

Deadly measles outbreaks on the rise, social media called to account

Firms called on to fight anti-vax fake news

- PMLiVE

The Real & The Honestly Fake

In the age of the Instagram filter and the selfie, there appears to be no place in healthcare creative for false perceptions. You’re either REAL, or you’re HONESTLY FAKE.

Page & Page and Partners

AstraZeneca AZ

US, EU regulators back rapid reviews of AZ’s RSV med

Positive top-line data triggered speedy assessments

Advance Outcomes

Pharma social media

Posting frequency is down as companies take a ‘less is more’ approach

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links